Back to search

Article

Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19

2020-11-23

Abstract excerpt

Drug repurposing provides a rapid approach to meet the urgent need for therapeutics to address COVID-19. To identify therapeutic targets relevant to COVID-19, we conducted Mendelian randomization (MR) analyses, deriving genetic instruments based on transcriptomic and proteomic data for 1,263 actionable proteins that are targeted by approved drugs or in clinical phase of drug development. Using summary statistics f...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
7b074900-8a16-5530-9b3c-7c0b5def54fc
DOI
10.1101/2020.11.19.20234120
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19DOI 10.1101/2020.11.19.20234120
Select a neighboring publication to make it the new centre.